News archive
19.12.2016
Dear friends! Materia Medica Holding Company wishes you a Merry Christmas and a Happy New Year 2017!
26.04.2016
Start-up meeting associated with initiation of clinical studies of Ergoferon
18.02.2016
Four extensive multicenter randomized trials have been completed which evaluated the safety and efficacy of two release-active drugs – liquid Ergoferon and Rengalin – in children and adults with acute respiratory infections (ARIs).
28.01.2016
Laboratory of Influenza under Pasteur Institute and APcis carried out a study in cooperation with Materia Medica Holding.
24.12.2015
Dear friends! Materia Medica Holding Company wishes you a Merry Christmas and a Happy New Year 2016!
11.11.2015
Officials of Mexico National Institute of Pediatrics confirmed recommendations on Anaferon for children application for prevention and treatment of acute infectious respiratory diseases
12.08.2015
Materia Medica expands manufacturing unit
28.07.2015
3rd Drug Discovery & Therapy World Congress
16.06.2015
First Russian GMP certificate
14.05.2015
7 International Congress of Antibodies
20.12.2013
Antiviral drug ANAFERON became the laureate of Premium “Brand of the Year No. 1 in Russia” in Kremlin!
14.10.2013
Anaferon for children has been recognized by European Respiratory Society as an effective drug for the treatment of recurring viral upper respiratory infections in children with bronchial asthma
05.06.2013
23rd Congress on Clinical Microbiology and Infectious Diseases (Berlin)
08.05.2013
The trial of Anaferon for children in Vietnam
24.04.2013
GMP certificate
23.04.2013
Impaza medicine is registered in Mexico
22.04.2013
ISO 9001-2011 (ISO 9001:2008) Quality Management Systems - Audited and Certified
15.04.2013
Impaza has been authorized in Mexico